Literature DB >> 214164

Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase.

G Mauco, H Chap, M F Simon, L Douste-Blazy.   

Abstract

Incubation of 32P-labelled platelets with Clostridium welchii phospholipase C greatly stimulates 32P-incorporation into phosphatidic and lysophosphatidic acids. A net synthesis is demonstrated for both phospholipids, which exhibit identical specific radioactivities. Phosphatidic acid production roughly parallels the phospholipase C-induced aggregation, whereas lysophosphatidic acid appears secondarily during cell lysis. The same qualitative variations are observed during thrombin-induced aggregation. At the physiological pH used throughout the incubations, platelets display no phospholipase A activity towards phosphatidic acid, whereas diglycerides are deacylated by platelet lysates. On the basis of these findings, a mechanism for phosphatidic and lysophosphatidic acid production is proposed, involving a phosphorylation of the di- and monoglycerides formed upon phospholipase C and lipase action. The possible role of such a pathway in regulating arachidonic acid release from phospholipids during platelet activation is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 214164     DOI: 10.1016/s0300-9084(78)80784-6

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  36 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

2.  Liberation of [3H]arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen.

Authors:  W K Pollock; T J Rink; R F Irvine
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

3.  CRE and SRE mediate LPA-induced CCN1 transcription in mouse aortic smooth muscle cells.

Authors:  Quanlin Dou; Feng Hao; Longsheng Sun; Xuemin Xu; Mei-Zhen Cui
Journal:  Can J Physiol Pharmacol       Date:  2016-12-17       Impact factor: 2.273

4.  A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.

Authors:  J S Saulnier-Blache; A Girard; M F Simon; M Lafontan; P Valet
Journal:  J Lipid Res       Date:  2000-12       Impact factor: 5.922

5.  Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets.

Authors:  J M Gerrard; S E Kindom; D A Peterson; J G White
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

6.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

Authors:  T Eichholtz; K Jalink; I Fahrenfort; W H Moolenaar
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

7.  Lysophosphatidic acid stimulates glucose transport in Xenopus oocytes via a phosphatidylinositol 3'-kinase with distinct properties.

Authors:  F J Thomson; C Moyes; P H Scott; R Plevin; G W Gould
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

8.  Activation of phospholipase C and prostaglandin synthesis by [arginine]vasopressin in cultures.

Authors:  J Pfeilschifter; A Kurtz; C Bauer
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

9.  Diglyceride lipase: a pathway for arachidonate release from human platelets.

Authors:  R L Bell; D A Kennerly; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

Review 10.  Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

Authors:  Lorenzo Federico; Zehra Pamuklar; Susan S Smyth; Andrew J Morris
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.